The Evolution of Cervical Cancer Screening: from Paps to Precise Personalized Programs

Sponsored by: BD

C.E. Credits: P.A.C.E. CE ｜ Florida CE

Speaker

Dr. Anu Rebbapragada

Director and Senior Advisor for Diagnostic Strategy and Services, Microbix Biosystems Inc.
BIOGRAPHY

Event Date & Time

Date: January 19, 2023

Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET)

Abstract

There has been an evolution of organized HPV screening programs from the pap smear to liquid-based cytology, which has brought dramatic reductions in cervical cancer incidence. However, there are still inconsistencies in testing methods and low screening rates across Canada due to COVID-19. This lecture will review the evolution of cervical cancer screening, the current Canadian landscape, and potential strategies for the current and evolving challenges with HPV testing.

Learning Objectives

Discuss an overview of Cervical Cancer Screening
Demonstrate the current state of the Canadian Landscape
Review Critical Challenges - Diagnostic Access and Risk Replacement
Uncover Potential Solutions - Self Collection, Risk Stratification and Risk Replacement

Webinars will be available for unlimited on-demand viewing after live event.

Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

The Evolution of Cervical Cancer Screening: from Paps to Precise Personalized Programs

Dr. Anu Rebbapragada